Lipocine Inc. Files 8-K
Ticker: LPCN · Form: 8-K · Filed: Aug 26, 2025 · CIK: 1535955
| Field | Detail |
|---|---|
| Company | Lipocine Inc. (LPCN) |
| Form Type | 8-K |
| Filed Date | Aug 26, 2025 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-filing, 8-K
Related Tickers: LPCN
TL;DR
LPCN filed a routine 8-K, nothing major to see here.
AI Summary
Lipocine Inc. filed an 8-K on August 26, 2025, reporting other events and financial statements. The company, previously known as Marathon Bar Corp until November 30, 2011, is incorporated in Delaware and headquartered in Salt Lake City, Utah. This filing does not appear to contain specific financial transaction details or significant business updates beyond routine reporting.
Why It Matters
This filing indicates routine corporate reporting by Lipocine Inc. to the SEC, which is standard practice for publicly traded companies.
Risk Assessment
Risk Level: low — The filing appears to be a standard corporate disclosure without any immediate negative or positive financial implications.
Key Players & Entities
- Lipocine Inc. (company) — Registrant
- Marathon Bar Corp (company) — Former company name
- 20111130 (date) — Date of name change
- August 26, 2025 (date) — Date of report
- 675 Arapeen Drive, Suite 202 (address) — Principal executive offices
- Salt Lake City, Utah (location) — Headquarters
FAQ
What is the primary purpose of this 8-K filing for Lipocine Inc.?
The filing is a Current Report on Form 8-K, reporting 'Other Events' and 'Financial Statements and Exhibits' as of August 26, 2025.
When was Lipocine Inc. formerly known by another name?
Lipocine Inc. was formerly known as Marathon Bar Corp, with a date of name change on November 30, 2011.
Where is Lipocine Inc.'s principal executive office located?
The principal executive offices are located at 675 Arapeen Drive, Suite 202, Salt Lake City, Utah 84108.
What is the Commission File Number for Lipocine Inc.?
The Commission File Number for Lipocine Inc. is 001-36357.
What is the IRS Employer Identification Number for Lipocine Inc.?
The IRS Employer Identification Number for Lipocine Inc. is 99-0370688.
Filing Stats: 452 words · 2 min read · ~2 pages · Grade level 11.5 · Accepted 2025-08-26 09:30:10
Key Financial Figures
- $0.0001 — ch registered Common Stock, par value $0.0001 per share LPCN The NASDAQ Stock Mar
Filing Documents
- form8-k.htm (8-K) — 41KB
- ex99-1.htm (EX-99.1) — 14KB
- form8-k_001.jpg (GRAPHIC) — 6KB
- 0001493152-25-012325.txt ( ) — 235KB
- lpcn-20250826.xsd (EX-101.SCH) — 3KB
- lpcn-20250826_lab.xml (EX-101.LAB) — 33KB
- lpcn-20250826_pre.xml (EX-101.PRE) — 22KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. LIPOCINE INC. Date: August 26, 2025 By: /s/ Mahesh V. Patel Mahesh V. Patel President and Chief Executive Officer